1. Home
  2. RFL vs SRTS Comparison

RFL vs SRTS Comparison

Compare RFL & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • SRTS
  • Stock Information
  • Founded
  • RFL 2017
  • SRTS 2010
  • Country
  • RFL United States
  • SRTS United States
  • Employees
  • RFL N/A
  • SRTS N/A
  • Industry
  • RFL Real Estate
  • SRTS Medical/Dental Instruments
  • Sector
  • RFL Finance
  • SRTS Health Care
  • Exchange
  • RFL Nasdaq
  • SRTS Nasdaq
  • Market Cap
  • RFL 54.4M
  • SRTS 51.8M
  • IPO Year
  • RFL N/A
  • SRTS 2016
  • Fundamental
  • Price
  • RFL N/A
  • SRTS $3.45
  • Analyst Decision
  • RFL
  • SRTS Strong Buy
  • Analyst Count
  • RFL 0
  • SRTS 3
  • Target Price
  • RFL N/A
  • SRTS $8.00
  • AVG Volume (30 Days)
  • RFL 175.2K
  • SRTS 88.0K
  • Earning Date
  • RFL 11-05-2025
  • SRTS 11-13-2025
  • Dividend Yield
  • RFL N/A
  • SRTS N/A
  • EPS Growth
  • RFL N/A
  • SRTS N/A
  • EPS
  • RFL N/A
  • SRTS N/A
  • Revenue
  • RFL $732,000.00
  • SRTS $37,564,000.00
  • Revenue This Year
  • RFL N/A
  • SRTS N/A
  • Revenue Next Year
  • RFL N/A
  • SRTS $46.14
  • P/E Ratio
  • RFL N/A
  • SRTS N/A
  • Revenue Growth
  • RFL 35.56
  • SRTS 3.29
  • 52 Week Low
  • RFL $1.28
  • SRTS $3.03
  • 52 Week High
  • RFL $3.19
  • SRTS $9.33
  • Technical
  • Relative Strength Index (RSI)
  • RFL 40.95
  • SRTS 56.63
  • Support Level
  • RFL $1.35
  • SRTS $3.11
  • Resistance Level
  • RFL $1.38
  • SRTS $3.68
  • Average True Range (ATR)
  • RFL 0.09
  • SRTS 0.12
  • MACD
  • RFL 0.00
  • SRTS 0.09
  • Stochastic Oscillator
  • RFL 10.00
  • SRTS 75.32

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About SRTS Sensus Healthcare Inc.

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

Share on Social Networks: